Stockreport

Aligos Therapeutics, Inc. (ALGS) Reports Q3 Loss, Tops Revenue Estimates [Yahoo! Finance]

Aligos Therapeutics, Inc. - Common stock  (ALGS) 
PDF This compares to loss of $10.25 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of -42. [Read more]